Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the Cancer and Leukemia Group B.
      Google Scholar   
Citation:
J Clin Oncol vol 20 (10) 2429-40
Year:
2002
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
 
Grants:
CA 31946, CA 33601  
Corr. Author:
 
Authors:
                             
Networks:
 
Study
CALGB-9221
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Adult, Aged, Aged, 80 and over, Antimetabolites, Antineoplastic, Azacitidine, Blood Cell Count, Bone Marrow, Cross-Over Studies, Female, Humans, Injections, Subcutaneous, Leukemia, B-Cell, Male, Middle Aged, Myelodysplastic Syndromes, Remission Induction, Risk Factors, Treatment Outcome